Characteristics | HF patients (n = 9) | Non-HF patients (n = 8) | P value |
---|---|---|---|
Men | 6 (66.7%) | 7 (87.5%) | 0.576 |
Women | 3 (33.3%) | 1 (12.5%) | 0.576 |
Age (years) | 60.1 ± 14.3 | 51.8 ± 7.2 | 0.147 |
BMI (kg/m2) | 26.8 ± 3.1 | 25.6 ± 1.6 | 0.323 |
Hypertension | 3 (33.3%) | 1 (12.5%) | 0.576 |
Diabetes | 2 (22.2%) | 1 (12.5%) | >0.999 |
Previous MI | 0 (0%) | 0 (0%) | NA |
Smoking | 3 (33.3%) | 5 (62.5%) | 0.347 |
Hypercholesterolemia | 5 (55.6%) | 4 (50%) | >0.999 |
AMI | 8 (88.9%) | 3 (42.9%) | 0.106 |
NT-proBNP (pg/mL)a | 918.3 ± 848.5 | 62 ± 14.1 | <0.001 |
LVEF (%)a | 39.3 ± 8.4 | 66.8 ± 1.9 | 0.001 |
Medications | |||
Aspirin | 9 (100%) | 8 (100%) | NA |
Clopidogrel | 8 (88.9%) | 8 (100%) | >0.999 |
Beta blockers | 9 (100%) | 8 (100%) | NA |
ACE inhibitors | 9 (100%) | 8 (100%) | NA |
Statins | 9 (100%) | 8 (100%) | NA |
Diuretics | 7 (77.8%) | 1 (12.5%) | 0.015 |